Metrika

  • citati u SCIndeksu: [1]
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:3
  • preuzimanja u poslednjih 30 dana:0

Sadržaj

članak: 1 od 1  
2015, vol. 49, br. 3, str. 78-84
Funkcija štitaste žlezde kod bolesnika na hemodijalizi
aKlinički centar Kragujevac, Klinika za urologiju, nefrologiju i dijalizu, Srbija
bKlinički centar Kragujevac, Klinika za urologiju, nefrologiju i dijalizu, Srbija + Univerzitet u Kragujevcu, Fakultet medicinskih nauka, Srbija
cUniverzitet u Kragujevcu, Fakultet medicinskih nauka, Srbija + Klinički centar Kragujevac, Klinika za internu medicinu, Srbija
dUniverzitet u Kragujevcu, Fakultet medicinskih nauka, Srbija + Klinički centar Kragujevac, Klinika za oftalmologiju, Srbija
eUniverzitet u Kragujevcu, Fakultet medicinskih nauka, Srbija

e-adresamilalazarevic1@gmail.com
Sažetak
Cilj. Cilj studije bio je da se proceni funkcije štitaste žlezde kod bolesnika koji se leče redovnim hemodijalizama i odredi uticaj parametara hemodijalize na funkciju štitaste žlezde. Metode. Kliničko istraživanje je sprovedeno na 50 bolesnika od ukupnog broja bolesnika koji su se lečili redovnim hemodijalizama u Centru za nefrologiju i dijalizu Kliničkog centra 'Kragujevac' tokom 2014. godine. Svi bolesnici su klinički i laboratorijski ispitani (standardne laboratorijske analize, hormonski parametri funkcije štitaste žlezde TSH, fT3 i fT4 i parametri o kvalitetu hemodijalize - URR - Urea Reduction Ratio i Singl-Pool Index Kt/V). Za obradu rezultata korišćena je odgovarajuća statistička metodologija. Rezultati. U grupi ispitivanih bolesnika srednji nivo hormona fT3 u serumu bio je ispod donje granice referentnyh vrednosti, dok je srednji nivo hormona TSH i fT4 bio u granicama referentnih vrednosti. Smanjena funkcija štitaste žlezde registrovana je kod 8% bolesnika. Netiroidna bolest je registrovana kod 52% bolesnika. U ispitivanoj grupi bolesnika uticaj na funkciju štitaste žlezde ispoljili su sledeći faktori: Kt/V kao parametar adekvatnosti hemodijalize, koncentracija RTN (parathormon) u serumu < 150 i > 1000 pg/ml, koncentracija kalcijuma u serumu < 2,24 i > 2,54 mmol/ml. Zaključak. Završni stadijum bubrežne slabosti i hemodijaliza utiču na funkciju štitaste žlezde na više načina. Smanjena funkcija štitaste žlezde registrovana je kod 8% bolesnika. Netiroidna bolest registrovana je kod 52% bolesnika.
Reference
Adler, S.M., Wartofsky, L. (2007) The nonthyroidal illness syndrome. Endocrinology and metabolism clinics of North America, 36(3): 657-72, vi
Barreto-Chaves, M.L., de Souza, M.P., Fürstenau, C.R. (2011) Acute actions of thyroid hormone on blood vessel biochemistry and physiology. Current opinion in endocrinology, diabetes, and obesity, 18(5): 300-3
Basu, G., Mohapatra, A. (2012) Interactions between thyroid disorders and kidney disease. Indian journal of endocrinology and metabolism, 16(2): 204-13
Cheng, S.Y., Leonard, J.L., Davis, P.J. (2010) Molecular aspects of thyroid hormone actions. Endocr Rev, 31: 137-70
Chonchol, M., Lippi, G., Salvagno, G., Zoppini, G., Muggeo, M., Targher, G. (2008) Prevalence of subclinical hypothyroidism in patients with chronic kidney disease. Clinical journal of the American Society of Nephrology, 3(5): 1296-300
Docter, R., Krenning, E.P., Jong, M., Hennemann, G. (1993) The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clinical Endocrinology, 39(5): 499-518
Dousdampanis, P., Trigka, K., Vagenakis, G.A., Fourtounas, C. (2014) The thyroid and the kidney: a complex interplay in health and disease. Int J Artif Organs, 37: 1-12
Duarte-Guterman, P., Navarro-Martín, L., Trudeau, V.L. (2014) Mechanisms of crosstalk between endocrine systems: Regulation of sex steroid hormone synthesis and action by thyroid hormones. General and Comparative Endocrinology, 203: 69-85
Enia, G., Panuccio, V., Cutrupi, S., Pizzini, P., Tripepi, G., Mallamaci, F., Zoccali, C. (2007) Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis. Nephrology, dialysis, transplantation, 22(2): 538-44
Feinstein, E.I., Kaptein, E.M., Nicoloff, J.T., Massry, S.G. (1982) Thyroid function in patients with nephrotic syndrome and normal renal function. American journal of nephrology, 2(2): 70-6
Fernández-Reyes, M.J., Diez, J.J., Collado, A., Iglesias, P., Bajo, M.A., Estrada, P., Del, P.G., Heras, M., Molina, A., Selgas, R. (2010) Are low concentrations of serum triiodothyronine a good marker for long-term mortality in hemodialysis patients?. Clinical nephrology, 73(3): 238-40
Hegedüs, L., Andersen, J.R., Poulsen, L.R., Perrild, H., Holm, B., Gundtoft, E., Hansen, J.M. (1985) Thyroid gland volume and serum concentrations of thyroid hormones in chronic renal failure. Nephron, 40(2): 171-4
Hekmat, R., Javadi, Z., Javain, M.L., Bonakdaran, S. (2011) Protective effect of low serum thyroid hormone concentration on occurrence of functional delayed kidney allograft function early after transplantation. Transplantation proceedings, 43(2): 516-8
Iglesias, P., Díez, J.J. (2009) Thyroid dysfunction and kidney disease. European journal of endocrinology, 160(4): 503-15
Kaptein, E.M., Quion-Verde, H., Chooljian, C.J., Tang, W.W., Friedman, P.E., Rodriquez, H.J., Massry, S.G. (1988) The thyroid in end-stage renal disease. Medicine, 67(3): 187-97
Kaptein, E.M. (1996) Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocrine reviews, 17(1): 45-63
Kulkarni, D.P., Holley, J.L. (2014) Thyroid Function Tests in End-Stage Renal Disease. Seminars in Dialysis, 27(6): 552-555
Łebkowska, U., Malyszko, J., Myśliwiec, M. (2003) Thyroid function and morphology in kidney transplant recipients, hemodialyzed, and peritoneally dialyzed patients. Transplantation proceedings, 35(8): 2945-8
Lim, V.S. (2001) Thyroid function in patients with chronic renal failure. Am J Kidney Dis, 38(4 Suppl 1): 0-4
Lo, J.C., Chertow, G.M., Go, A.S., Hsu, C. (2005) Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int, 67(3): 1047-52
Malyszko, J., Malyszko, J.S., Pawlak, K., Mysliwiec, M. (2007) Thyroid function, endothelium, and inflammation in hemodialyzed patients: possible relations?. Journal of renal nutrition, 17(1): 30-7
Mariani, L.H., Berns, J.S. (2012) The renal manifestations of thyroid disease. Journal of the American Society of Nephrology, 23(1): 22-6
Ng, Y.Y., Lin, H.D., Wu, S.C., Yang, C.Y., Yang, W.C., Liou, H.H., Hu, F.H., Hou, C.C., Tseng, S.S., Ku, N.Y. (2013) Impact of thyroid dysfunction on erythropoietin dosage in hemodialysis patients. Thyroid, 23(5): 552-61
Niemczyk, S., Niemczyk, L., Romejko-Ciepielewska, K. (2012) Basic endocrinological disorders in chronic renal failure. Endokrynologia Polska, 63(3): 250-7
Ozen, K.P., Asci, G., Gungor, O., Carrero, J.J., Kircelli, F., Tatar, E., Sevinc, O.E., Ozkahya, M., Toz, H., Cirit, M. (2011) Nutritional state alters the association between free triiodothyronine levels and mortality in hemodialysis patients. American journal of nephrology, 33(4): 305-12
Ramirez, G. (1976) Thyroid Dysfunction in Uremia: Evidence for Thyroid and Hypophyseal Abnormalities. Annals of Internal Medicine, 84(6): 672
Rotondi, M., Netti, G.S., Rosati, A., i dr. (2008) Pretransplant serum FT3 levels in kidney graft recipients are useful for identifying patients with higher risk for graft failure. Clin Endocrinol, 68: 220-5
Wiederkehr, M.R., Kalogiros, J., Krapf, R. (2004) Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients. Nephrology, dialysis, transplantation, 19(5): 1190-7
Yen, P.M. (2001) Physiological and molecular basis of thyroid hormone action. Physiol Rev, 81(3): 1097-142
Zoccali, C., Tripepi, G., Cutrupi, S., Pizzini, P., Mallamaci, F. (2005) Low triiodothyronine: a new facet of inflammation in end-stage renal disease. Journal of the American Society of Nephrology, 16(9): 2789-95
 

O članku

jezik rada: srpski
vrsta rada: stručni članak
DOI: 10.5937/mckg49-9065
objavljen u SCIndeksu: 16.03.2016.

Povezani članci

Nema povezanih članaka